Which has the lower trailing P/E, GSK or HCA?

HCA has the lower trailing P/E: GSK trades at 15.57 and HCA at 14.58. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, GSK or HCA?

Over the past five years, HCA grew revenue faster — GSK at a 1.38% CAGR versus HCA at 6.85%.

Does GSK or HCA pay a bigger dividend?

GSK yields 3.78% and HCA yields 0.70% based on trailing dividends and the latest price.

Is GSK or HCA more profitable?

GSK runs the higher net margin — GSK at 14.52% versus HCA at 8.77%.

How have GSK and HCA total returns compared?

Over the past 10 years, GSK delivered 6.11% and HCA delivered 19.72% annualized total return. Past performance doesn't predict future results.

GSK plc (GSK) vs HCA Healthcare, Inc. (HCA)

A side-by-side comparison of GSK plc and HCA Healthcare, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

GSK

GSK plc

$98.65B

$49.24HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

HCA

HCA Healthcare, Inc.

$94.31B

$435.61HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

Total return — GSK vs HCA

growth of $100 · dividends reinvested · last 10y

GSK +76.2% (+5.8%/yr)HCA +512.0% (+19.9%/yr)HCA compounded faster over this window

GSK HCA

GSK vs HCA: by the numbers

•GSK is the larger company ($98.65B vs $94.31B market cap).
•HCA trades at the lower trailing earnings multiple (14.58 vs 15.57 P/E), one valuation lens rather than an overall verdict.
•GSK converts more revenue to profit (14.52% vs 8.77% net margin).
•HCA grew revenue faster over the past five years (6.85% vs 1.38% CAGR).
•GSK pays the higher dividend yield (3.78% vs 0.70%).

Metrics side by side

Valuation

Metric	GSK	HCA
P/E ratio	15.57	14.58
Forward P/E	N/A	14.78
P/S ratio	2.23	1.21
P/B ratio	4.24	N/A
EV / EBITDA	7.97	9.02
FCF yield	9.46%	6.36%

Profitability

Metric	GSK	HCA
Gross margin	72.71%	41.50%
Operating margin	20.72%	15.48%
Net margin	14.52%	8.77%
ROE	27.67%	N/A
ROIC	13.95%	19.41%

Dividends

Metric	GSK	HCA
Dividend yield	3.78%	0.70%
Payout ratio	57.45%	10.04%

Growth (annualized)

Metric	GSK	HCA
Revenue CAGR (5Y)	1.38%	6.85%
EPS CAGR (5Y)	-0.71%	20.90%
FCF CAGR (5Y)	-2.45%	56.45%
Total return CAGR (5Y)	8.21%	11.63%

Frequently asked

Which has the lower trailing P/E, GSK or HCA?: HCA has the lower trailing P/E: GSK trades at 15.57 and HCA at 14.58. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, GSK or HCA?: Over the past five years, HCA grew revenue faster — GSK at a 1.38% CAGR versus HCA at 6.85%.
Does GSK or HCA pay a bigger dividend?: GSK yields 3.78% and HCA yields 0.70% based on trailing dividends and the latest price.
Is GSK or HCA more profitable?: GSK runs the higher net margin — GSK at 14.52% versus HCA at 8.77%.
How have GSK and HCA total returns compared?: Over the past 10 years, GSK delivered 6.11% and HCA delivered 19.72% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GSK analysis Full HCA analysis Interactive comparison tool

Dig into the metrics

GSK P/E ratio HCA Healthcare P/E ratio GSK dividend yield HCA Healthcare dividend yield GSK ROE HCA Healthcare ROE GSK operating margin HCA Healthcare operating margin GSK revenue growth HCA Healthcare revenue growth GSK free cash flow HCA Healthcare free cash flow

GSK & HCA Healthcare appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.